Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer
NAGIOS: RODERIC FUNCIONANDO

Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer

DSpace Repository

Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer

Show full item record

View       (1.403Mb)

    
Tabchy, Adel; Valero, Vicente; Vidaurre, Tatiana; Lluch Hernández, Ana Perfil; Gomez, Henry; Martín, Miguel; Qi, Yuan; Barajas-Figueroa, Luis Javier; Souchon, Eduardo; Coutant, Charles; Doimi, Franco D.; Ibrahim, Nuhad K; Gong, Yun; Hortobagyi, Gabriel N.; Hess, Kenneth R.; Symmans, W. Fraser; Pusztai, Lajos
This document is a artículoDate2010

Este documento está disponible también en : http://hdl.handle.net/10550/44799

    Clinical cancer research : an official journal of the American Association for Cancer Research Vol. 16 Issue 21: pp. 5351-5361

This item appears in the following Collection(s)

Show full item record

Search DSpace

Advanced Search

Browse

Statistics